0001070081-18-000017.txt : 20180105
0001070081-18-000017.hdr.sgml : 20180105
20180105160806
ACCESSION NUMBER: 0001070081-18-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180103
FILED AS OF DATE: 20180105
DATE AS OF CHANGE: 20180105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Souza Marcio
CENTRAL INDEX KEY: 0001707657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 18513501
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
wf-form4_151518647228588.xml
FORM 4
X0306
4
2018-01-03
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001707657
Souza Marcio
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
Chief Operating Officer
Common Stock
2018-01-03
4
A
0
1079
0
A
1742
I
By Spouse
Stock Option (Right To Buy)
18.01
2018-01-03
4
A
0
75000
0
A
2028-01-02
Common Stock
75000.0
75000
D
Stock Option (Right To Buy)
18.01
2018-01-03
4
A
0
2696
0
A
2028-01-02
Common Stock
2696.0
2696
I
By Spouse
Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2019. Upon vesting, each RSU will convert into one share of the issuer.
Includes 663 shares acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2017.
This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
/s/ Avraham S. Adler, attorney-in-fact
2018-01-05